Table 1.
Mean (SD) or n/% | |
---|---|
Demographics | |
Age, years | 49.6 (10.72) |
Body mass index, kg/m2 | 27.5 (6.03) |
White | 25/78.1% |
Latina | 5/15.6% |
Education (% college graduates) | 20/62.5% |
Married of living with partner | 17/53.1% |
Employed | 22/68.8% |
Self-reported functioning | |
Cognitive | 51.9 (10.92) |
Physical | 54.0 (6.11) |
Cancer characteristics | |
Disease stage | |
Stage I | 5/15.6% |
Stage II | 19/59.4% |
Stage III | 6/18.8% |
Stage IV | 2/6.3% |
Receptor type | |
HER2+ | 9/28.1% |
ER+ or PR+, HER2- | 12/37.5% |
Triple-negative (ER–, PR–, HER2–) | 11/34.4% |
Pathologically positive lymph nodes | 18/58.1% |
Mastectomy | 9/28.1% |
Number of chemotherapy infusions | 9.7 (6.02) |
Chemotherapy duration, weeks | 17.3 (6.26) |